2.0ATA Hbot Hyperbaric Oxygen Chamber Double Person Large Capacity Diving Decompression

Name: 2.0ATA Hbot Hyperbaric Oxygen Chamber Double Person Large Capacity Diving Decompression
Brand: Nanjing Kingshare Biotechnology Co., Ltd.
SKU: 2292189905

Jiangsu, ChinaNanjing Kingshare Biotechnology Co., Ltd.

US$13,999.00-27,999.00

1 Set

Product profile

Customization

Available

Product Name

Hbot Hyperbaric Oxygen Chamber 2.0ATA

Size

L2100*D2000*H1700mm

Model NO.

KX-YS01

Application

Health Care Physical Therapy Beauty Care

Chamber Pressure

2.0ATA

Certificate

CE/ISO/RoHS/Ukca

Power Source

Electric

Oxygen Purity

95%

Material

Aluminum Alloy

Voltage

110/220V

Oxygen Flow Rate

15L

Weight

470kg

Warranty

2 Year

Shelf Life

3 Year

MOQ

1 Set

OEM&ODM

Available

Transport Package

Plywood and Caron Box/Pallet

Trademark

Kingshare

Origin

China

Production Capacity

500sets/Month

Company profile

Standardized quality controlQuality AssuranceProduct CertificationFast Delivery

Nanjing Kingshare Biotechnology Co., Ltd.

Jiangsu, China

CertifiedBusiness Type: Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 3 Years CertifiedNearest Port: Shanghai PortAverage Response Time: ≤3.49h

AI-Powered supplier vetting

SummaryKingShare Biotech is presented as a vertically integrated biotechnology solutions provider with more than 20 years of experience and its own manufacturing facility exceeding 5,000 square meters. It reports professional R&D capability, 3D software design, broad customization services, documented design controls, and technical support covering production and after-sales service. Production information includes annual output of 10,800 hyperbaric oxygen chamber sets, inventory capability, and standardized finished-product inspection instructions. However, only one QA/QC inspector is reported, and the supplier lacks overseas warehouses, showrooms, agents, or branches. Service-capability supplier management is weakly documented, with no written assessment procedures, approved-supplier list, or corrective/preventive-action records. Financial credibility cannot be favorably assessed because the provided financial data is zero-valued and incomplete. No certifications or customer cases are explicitly provided.

Supplier typeThe supplier identifies itself as a vertically integrated biotechnology solutions provider with its own manufacturing facility and global B2B sales models. Its stated business scope includes medical-device production and sales of separation, purification, and mechanical equipment, supporting classification as a manufacturer and technical solution supplier.

After-Sales capabilityTechnology engineers are responsible for technical support during production and after-sales service, indicating an internal after-sales support function. However, the supplier reports no overseas warehouse, showroom, agent, or branch capability, so overseas service coverage appears limited.

R&D capabilityThe supplier reports professional R&D capability, 3D software design, broad product-design services, technical engineers for new-product development, and available design input/output, review, verification, and validation documentation. No SDK is available, which limits software-development integration capability but does not negate the documented product R&D capability.

Production capacityThe supplier operates its own manufacturing facility exceeding 5,000 square meters, reports annual production of 10,800 hyperbaric oxygen chamber sets, and has in-stock service capability. Finished-product inspection follows documented and uniformly applied instructions, although only one QA/QC inspector is reported.

Customization capabilityThe supplier explicitly offers customization from samples, customization from designs, full customization, minor customization, and flexible customization, supported by engineers who confirm customer requirements and design new products. The availability of design-control documentation further supports structured customization execution.